Johnson Controls International – Rising Net Sales & Segment EBITA Trends

By Bobby Samwell • Monday, May 05 15:23 • Permanent Link

The unaudited historical financial information released by the company shows some interesting trends in its net sales and segment EBITA for the fiscal years 2023, 2024, and 2025.

In terms of net sales, there has been a consistent increase year-over-year. In fiscal year 2023, the company reported total net sales of $22,331 million, which increased to $22,952 million in fiscal year 2025.

Looking at the segment EBITA, we see a similar trend of growth. In fiscal year 2023, the Americas segment reported EBITA of $2,343 million, which increased to $2,679 million in fiscal year 2025. Similarly, the EMEA segment's EBITA grew from $418 million in fiscal year 2023 to $561 million in fiscal year 2025. The APAC segment also saw an increase in EBITA from $609 million in fiscal year 2023 to $478 million in fiscal year 2025.

It's important to note that the company also reported adjusted segment EBITA, a non-GAAP measure, which excludes certain items. The adjusted segment EBITA for the Americas segment was $2,353 million in fiscal year 2024 and increased to $2,637 million in fiscal year 2025. For the EMEA segment, adjusted EBITA grew from $104 million in fiscal year 2024 to $136 million in fiscal year 2025. The APAC segment's adjusted EBITA also increased from $127 million in fiscal year 2024 to $158 million in fiscal year 2025.

These figures indicate a positive trend in the company's financial performance, with consistent growth in net sales and segment EBITA across its operating segments over the years. The market has reacted to these announcements by moving the company's shares 0.4% to a price of $89.32. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.